1. Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606). (August 2022) Authors: Ray, K.K.; Nicholls, S.; Ditmarsch, M.; Kastelein, J.J.; Rigby, S.; Kling, D.; Curcio, D.; Alp, N.; Davidson, M. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗